In advanced stage ovarian cancer, the presence of CD8+ cells, FoxP3+Treg or a high CD8/FoxP3 frequency ratio in tumor tissue was associated with an increased disease specific survival (15). This evidence concerns the gene FOXP3 and neoplasm.